Vic Branch | Tuberculosis update

6:30pm Wednesday, 21 October 2020
7:30pm Wednesday, 21 October 2020
Webinar

This presentation will provide an overview of recent updates in the treatment of TB.

Learning Objectives: 

  • Outline the use of rifampicin and isoniazid in latent TB treatment
  • Review updated drug resistant TB treatment options
  • Describe new oral agents available for treating drug resistant TB
  • Outline special considerations for HIV and TB co-infections

This webinar will commence at 6:30pm AEDT

Registration rates:

Member: Free
Non-member: $50

  • Register in the purple box below, then click on 'cart' at the top of the page (or under your menu options) and continue through checkout.
  • Still having trouble registering? Follow our handy ‘how to’ guide
  • Click here to view our Terms and Conditions

 

* You will receive a confirmation email upon completion of your registration. If you do not receive this within 4 hours, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing events@shpa.org.au.

Sold Out

Contact Information

Additional Information

Speakers: 

  • Dr Grant Jenkin, Director, Mycobacterial Infections Service, Monash Health; Infectious Diseases Consultant, Monash Health, Melbourne, Vic
  • Amelia Rattle, Clinical Pharmacist & Special Medicine Pharmacy Co-Team Leader, Monash Health, Melbourne, Vic

Competency Standards:

  • Standard 3.1.2 Assess medication management practices and needs
  • Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
  • Standard 3.3.2 Apply clinical review findings to improve health outcomes

National Competency Standards Framework for Pharmacists in Australia, 2016

Accreditation:

This activity has been accredited for 1 hour of Group-1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2020/62.

APC